Skip to main content
Clinical Trials/NL-OMON38509
NL-OMON38509
Completed
Not Applicable

Changes in the lymph nodes during the earliest phases of rheumatoid arthritis - Lymph nodes in the earliest phases of rheumatoid arthritis

Academisch Medisch Centrum0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
arthritis
Sponsor
Academisch Medisch Centrum
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy controls: negative for IgM\-RF and anti\-CCP antibodies
  • Autoantibody\-positive individuals: positive for IgM\-RF and/or anti\-CCP antibodies \+ either arthralgia or a first degree relative with RA.
  • Early arthritis patients: arthritis \< 1 year, disease\-modifying antirheumatic drug (DMARD) naive \+ classified as RA according to the 2010 ACR/EULAR criteria for RA or as unclassified arthritis (UA).

Exclusion Criteria

  • For all individuals:
  • \- Current/previous use of disease modifying anti\-rheumatic drugs (DMARDs).
  • \- If applicable: patients in whom anticoagulant therapy cannot be temporarily stopped before the procedure
  • \- Systemic prednisolone use less then 28 days before enrolment
  • \- Present or previous treatment with any cell depleting therapies, including investigational agents (e.g. CAMPATH, anti\-CD4, anti\-CD5, anti\-CD3, anti\-CD19\)
  • \- Presence of any disease for which study subjects need chronic or intermittent immunosuppressive therapy (e.g. prednisolone for COPD).
  • \- History of chronic viral infection
  • \- History of autoimmune diseases
  • \- History of malignancies

Outcomes

Primary Outcomes

Not specified

Similar Trials